Skip to main content
SpringerLink
Log in

Proteogenomics for the Study of Gastrointestinal Stromal Tumors

  • Chapter
  • First Online:
Proteogenomics

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 926))

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. Gain-of-function mutations in KIT or platelet-derived growth factor receptor alpha (PDGFRA) drive most GISTs, and 85 % of GISTs also contain oncogenic mutations in one of two receptor tyrosine kinases. The advent of tyrosine kinase inhibitors has had a significant impact on the clinical practices for GISTs. However, tumors in more than 80 % of GIST patients acquire resistance against treatments with tyrosine kinase inhibitors; thus, driver mechanisms of secondary resistance as well as biomarkers for early detection of recurrence have been explored for better clinical outcomes. Proteomics is a versatile and straightforward approach to finding the molecular basis of malignancies as well as the innovative seeds for clinical applications. Comprehensive genome, epigenome, and transcriptome data have already been obtained and examined together in GISTs, and proteome data has a unique additional value in multi-omics studies. Various types of samples were examined using proteomics modalities in GIST, suggest the promising utility of proteomic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agaram, N. P., Laquaglia, M. P., Ustun, B., Guo, T., Wong, G. C., Socci, N. D., Maki, R. G., DeMatteo, R. P., Besmer, P., & Antonescu, C. R. (2008). Molecular characterization of pediatric gastrointestinal stromal tumors. Clinical Cancer Research, 14(10), 3204–3215. doi:10.1158/1078-0432.CCR-07-1984.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Antonescu, C. R., Besmer, P., Guo, T., Arkun, K., Hom, G., Koryotowski, B., Leversha, M. A., Jeffrey, P. D., Desantis, D., Singer, S., Brennan, M. F., Maki, R. G., & DeMatteo, R. P. (2005). Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clinical Cancer Research, 11(11), 4182–4190. doi:10.1158/1078-0432.CCR-04-2245.

    Article  CAS  PubMed  Google Scholar 

  • Arne, G., Kristiansson, E., Nerman, O., Kindblom, L. G., Ahlman, H., Nilsson, B., & Nilsson, O. (2011). Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis. International Journal of Cancer, 129(5), 1149–1161. doi:10.1002/ijc.25755.

    Article  CAS  PubMed  Google Scholar 

  • Basaki, Y., Hosoi, F., Oda, Y., Fotovati, A., Maruyama, Y., Oie, S., Ono, M., Izumi, H., Kohno, K., Sakai, K., Shimoyama, T., Nishio, K., & Kuwano, M. (2007). Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene, 26(19), 2736–2746. doi:10.1038/sj.onc.1210084.

    Article  CAS  PubMed  Google Scholar 

  • Brenca, M., Rossi, S., Polano, M., Gasparotto, D., Zanatta, L., Racanelli, D., Valori, L., Lamon, S., Dei Tos, A. P., & Maestro, R. (2015). Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST. The Journal of Pathology. doi:10.1002/path.4677.

    Google Scholar 

  • Bustin, M. (1999). Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Molecular and Cellular Biology, 19(8), 5237–5246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen, L. L., Trent, J. C., Wu, E. F., Fuller, G. N., Ramdas, L., Zhang, W., Raymond, A. K., Prieto, V. G., Oyedeji, C. O., Hunt, K. K., Pollock, R. E., Feig, B. W., Hayes, K. J., Choi, H., Macapinlac, H. A., Hittelman, W., Velasco, M. A., Patel, S., Burgess, M. A., Benjamin, R. S., & Frazier, M. L. (2004). A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Research, 64(17), 5913–5919. doi:10.1158/0008-5472.CAN-04-0085.

    Article  CAS  PubMed  Google Scholar 

  • Choi, Y. R., Kim, H., Kang, H. J., Kim, N. G., Kim, J. J., Park, K. S., Paik, Y. K., Kim, H. O., & Kim, H. (2003). Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Research, 63(9), 2188–2193.

    CAS  PubMed  Google Scholar 

  • Clary, B. M., DeMatteo, R. P., Lewis, J. J., Leung, D., & Brennan, M. F. (2001). Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: A clinical comparison. Annals of Surgical Oncology, 8(4), 290–299.

    Article  CAS  PubMed  Google Scholar 

  • Corless, C. L., & Heinrich, M. C. (2008). Molecular pathobiology of gastrointestinal stromal sarcomas. Annual Review of Pathology, 3, 557–586. doi:10.1146/annurev.pathmechdis.3.121806.151538.

    Article  CAS  PubMed  Google Scholar 

  • Corless, C. L., Barnett, C. M., & Heinrich, M. C. (2011). Gastrointestinal stromal tumours: Origin and molecular oncology. Nature Reviews Cancer, 11(12), 865–878.

    CAS  PubMed  Google Scholar 

  • Cox, B. D., Natarajan, M., Stettner, M. R., & Gladson, C. L. (2006). New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. Journal of Cellular Biochemistry, 99(1), 35–52. doi:10.1002/jcb.20956.

    Article  PubMed  Google Scholar 

  • DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000). Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Annals of Surgery, 231(1), 51–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dematteo, R. P., Heinrich, M. C., El-Rifai, W. M., & Demetri, G. (2002). Clinical management of gastrointestinal stromal tumors: Before and after STI-571. Human Pathology, 33(5), 466–477. doi:S0046817702000163 [pii].

    Article  CAS  PubMed  Google Scholar 

  • Dematteo, R. P., Ballman, K. V., Antonescu, C. R., Maki, R. G., Pisters, P. W., Demetri, G. D., Blackstein, M. E., Blanke, C. D., von Mehren, M., Brennan, M. F., Patel, S., McCarter, M. D., Polikoff, J. A., Tan, B. R., Owzar, K., & American College of Surgeons Oncology Group Intergroup Adjuvant GST. (2009). Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: A randomised, double-blind, placebo-controlled trial. Lancet, 373(9669), 1097–1104. doi:10.1016/S0140-6736(09)60500-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., Fletcher, J. A., Silverman, S. G., Silberman, S. L., Capdeville, R., Kiese, B., Peng, B., Dimitrijevic, S., Druker, B. J., Corless, C., Fletcher, C. D., & Joensuu, H. (2002). Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine, 347(7), 472–480. doi:10.1056/NEJMoa020461347/7/472 [pii].

    Article  CAS  PubMed  Google Scholar 

  • Demetri, G. D., Reichardt, P., Kang, Y. K., Blay, J. Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., von Mehren, M., Joensuu, H., Badalamenti, G., Blackstein, M., Le Cesne, A., Schoffski, P., Maki, R. G., Bauer, S., Nguyen, B. B., Xu, J., Nishida, T., Chung, J., Kappeler, C., Kuss, I., Laurent, D., Casali, P. G., & investigators Gs. (2013). Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): An international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet, 381(9863), 295–302. doi:10.1016/S0140-6736(12)61857-1.

    Article  CAS  PubMed  Google Scholar 

  • Deutsch, E. W., Albar, J. P., Binz, P. A., Eisenacher, M., Jones, A. R., Mayer, G., Omenn, G. S., Orchard, S., Vizcaino, J. A., & Hermjakob, H. (2015). Development of data representation standards by the human proteome organization proteomics standards initiative. Journal of the American Medical Informatics Association: JAMIA, 22(3), 495–506. doi:10.1093/jamia/ocv001.

    PubMed  PubMed Central  Google Scholar 

  • Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H., & O’Leary, T. J. (1999). Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site. The American Journal of Surgical Pathology, 23(1), 82–87.

    Article  CAS  PubMed  Google Scholar 

  • Fletcher, C. D., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O’Leary, T. J., Remotti, H., Rubin, B. P., Shmookler, B., Sobin, L. H., & Weiss, S. W. (2002). Diagnosis of gastrointestinal stromal tumors: A consensus approach. Human Pathology, 33(5), 459–465. doi:S0046817702000151 [pii].

    Article  PubMed  Google Scholar 

  • Fowler, C. B., O’Leary, T. J., & Mason, J. T. (2013). Toward improving the proteomic analysis of formalin-fixed, paraffin-embedded tissue. Expert Review of Proteomics, 10(4), 389–400. doi:10.1586/14789450.2013.820531.

    Article  CAS  PubMed  Google Scholar 

  • Gurrieri, C., Capodieci, P., Bernardi, R., Scaglioni, P. P., Nafa, K., Rush, L. J., Verbel, D. A., Cordon-Cardo, C., & Pandolfi, P. P. (2004). Loss of the tumor suppressor PML in human cancers of multiple histologic origins. Journal of the National Cancer Institute, 96(4), 269–279.

    Article  CAS  PubMed  Google Scholar 

  • Haller, F., Zhang, J. D., Moskalev, E. A., Braun, A., Otto, C., Geddert, H., Riazalhosseini, Y., Ward, A., Balwierz, A., Schaefer, I. M., Cameron, S., Ghadimi, B. M., Agaimy, A., Fletcher, J. A., Hoheisel, J., Hartmann, A., Werner, M., Wiemann, S., & Sahin, O. (2015). Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor. International Journal of Cancer, 136(5), 1013–1023. doi:10.1002/ijc.29088.

    Article  CAS  PubMed  Google Scholar 

  • Hara, R., Kikuchi, H., Setoguchi, T., Miyazaki, S., Yamamoto, M., Hiramatsu, Y., Kamiya, K., Ohta, M., Baba, S., & Konno, H. (2015). Microarray analysis reveals distinct gene set profiles for gastric and intestinal gastrointestinal stromal tumors. Anticancer Research, 35(6), 3289–3298.

    CAS  PubMed  Google Scholar 

  • Hasegawa, T., Asanuma, H., Ogino, J., Hirohashi, Y., Shinomura, Y., Iwaki, H., Kikuchi, H., & Kondo, T. (2013). Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor. Human Pathology, 44(7), 1271–1277. doi:10.1016/j.humpath.2012.10.013. S0046-8177(12)00381-4 [pii].

    Article  CAS  PubMed  Google Scholar 

  • Heinrich, M. C., Corless, C. L., Blanke, C. D., Demetri, G. D., Joensuu, H., Roberts, P. J., Eisenberg, B. L., von Mehren, M., Fletcher, C. D., Sandau, K., McDougall, K., Ou, W. B., Chen, C. J., & Fletcher, J. A. (2006). Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. Journal of Clinical Oncology, 24(29), 4764–4774. doi:10.1200/JCO.2006.06.2265.

    Article  CAS  PubMed  Google Scholar 

  • Hensley, M. L., Maki, R., Venkatraman, E., Geller, G., Lovegren, M., Aghajanian, C., Sabbatini, P., Tong, W., Barakat, R., & Spriggs, D. R. (2002). Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial. Journal of Clinical Oncology, 20(12), 2824–2831.

    Article  CAS  PubMed  Google Scholar 

  • Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Muhammad Tunio, G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y., & Kitamura, Y. (1998). Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 279(5350), 577–580.

    Article  CAS  PubMed  Google Scholar 

  • Ichikawa, H., Yoshida, A., Kanda, K., Kosugi, S., Ichikawa, T., Hanyu, T., Taguchi, T., Sakumoto, M., Katai, H., Kawai, A., Wakai, T., & Kondo, T. (2014). Prognostic significance of PML expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis. Cancer Science, 106(1), 115–124.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jiang, J., Jin, M. S., Suo, J., Wang, Y. P., He, L., & Cao, X. Y. (2012). Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. World Journal of Gastroenterology, 18(20), 2569–2575. doi:10.3748/wjg.v18.i20.2569.

    Article  PubMed  PubMed Central  Google Scholar 

  • Joensuu, H. (2006). Gastrointestinal stromal tumor (GIST). Annals of Oncology, 17(Suppl 10), x280–x286. doi:10.1093/annonc/mdl274.

    Article  PubMed  Google Scholar 

  • Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human Pathology, 39(10), 1411–1419. doi:10.1016/j.humpath.2008.06.025.

    Article  PubMed  Google Scholar 

  • Joensuu, H., Vehtari, A., Riihimaki, J., Nishida, T., Steigen, S. E., Brabec, P., Plank, L., Nilsson, B., Cirilli, C., Braconi, C., Bordoni, A., Magnusson, M. K., Linke, Z., Sufliarsky, J., Federico, M., Jonasson, J. G., Dei Tos, A. P., & Rutkowski, P. (2012). Risk of recurrence of gastrointestinal stromal tumour after surgery: An analysis of pooled population-based cohorts. The Lancet Oncology, 13(3), 265–274. doi:10.1016/S1470-2045(11)70299-6.

    Article  PubMed  Google Scholar 

  • Kang, H. J., Koh, K. H., Yang, E., You, K. T., Kim, H. J., Paik, Y. K., & Kim, H. (2006). Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics, 6(4), 1151–1157. doi:10.1002/pmic.200500372.

    Article  CAS  PubMed  Google Scholar 

  • Kang, R., Zhang, Q., Zeh, H. J., 3rd, Lotze, M. T., & Tang, D. (2013). HMGB1 in cancer: Good, bad, or both? Clinical Cancer Research, 19(15), 4046–4057. doi:10.1158/1078-0432.CCR-13-0495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kikuta, K., Gotoh, M., Kanda, T., Tochigi, N., Shimoda, T., Hasegawa, T., Katai, H., Shimada, Y., Suehara, Y., Kawai, A., Hirohashi, S., & Kondo, T. (2010). Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: Novel monoclonal antibody and external validation study in multiple clinical facilities. Japanese Journal of Clinical Oncology, 40(1), 60–72. doi:hyp125 [pii]10.1093/jjco/hyp125.

    Article  PubMed  Google Scholar 

  • Kikuta, K., Kubota, D., Saito, T., Orita, H., Yoshida, A., Tsuda, H., Suehara, Y., Katai, H., Shimada, Y., Toyama, Y., Sato, K., Yao, T., Kaneko, K., Beppu, Y., Murakami, Y., Kawai, A., & Kondo, T. (2012). Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. Journal of Proteomics, 75(4), 1089–1098. doi:10.1016/j.jprot.2011.10.005. S1874-3919(11)00491-X [pii].

    Article  CAS  PubMed  Google Scholar 

  • Kindblom, L. G., Remotti, H. E., Aldenborg, F., & Meis-Kindblom, J. M. (1998). Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. The American Journal of Pathology, 152(5), 1259–1269.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kondo, T., & Hirohashi, S. (2007). Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nature Protocols, 1(6), 2940–2956. doi:10.1038/nprot.2006.421.

    Article  Google Scholar 

  • Kondo, T., Kubota, D., & Kawai, A. (2012). Application of Proteomics to Soft Tissue Sarcomas. International Journal of Proteomics, 2012, 876401. doi:10.1155/2012/876401.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kondo, T., Suehara, Y., Kikuta, K., Kubota, D., Tajima, T., Mukaihara, K., Ichikawa, H., & Kawai, A. (2013). Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor. Proteomics Clinical Applications, 7(1-2), 70–78. doi:10.1002/prca.201200085.

    Article  CAS  PubMed  Google Scholar 

  • Kubota, D., Orita, H., Yoshida, A., Gotoh, M., Kanda, T., Tsuda, H., Hasegawa, T., Katai, H., Shimada, Y., Kaneko, K., Kawai, A., & Kondo, T. (2011). Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: Validation study in multiple clinical facilities. Japanese Journal of Clinical Oncology, 41(10), 1194–1202. doi:hyr121 [pii]10.1093/jjco/hyr121.

    Article  PubMed  Google Scholar 

  • Kubota, D., Okubo, T., Saito, T., Suehara, Y., Yoshida, A., Kikuta, K., Tsuda, H., Katai, H., Shimada, Y., Kaneko, K., Kawai, A., & Kondo, T. (2012). Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal yumour. Japanese Journal of Clinical Oncology, 42(8), 730–741. doi:hys092 [pii]10.1093/jjco/hys092.

    Article  PubMed  Google Scholar 

  • Ladoire, S., Penault-Llorca, F., Senovilla, L., Dalban, C., Enot, D., Locher, C., Prada, N., Poirier-Colame, V., Chaba, K., Arnould, L., Ghiringhelli, F., Fumoleau, P., Spielmann, M., Delaloge, S., Poillot, M. L., Arveux, P., Goubar, A., Andre, F., Zitvogel, L., & Kroemer, G. (2015). Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy, 11(10), 1878–1890. doi:10.1080/15548627.2015.1082022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liegl, B., Kepten, I., Le, C., Zhu, M., Demetri, G. D., Heinrich, M. C., Fletcher, C. D., Corless, C. L., & Fletcher, J. A. (2008). Heterogeneity of kinase inhibitor resistance mechanisms in GIST. The Journal of Pathology, 216(1), 64–74. doi:10.1002/path.2382.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Linder, P., Lasko, P. F., Ashburner, M., Leroy, P., Nielsen, P. J., Nishi, K., Schnier, J., & Slonimski, P. P. (1989). Birth of the D-E-A-D box. Nature, 337(6203), 121–122. doi:10.1038/337121a0.

    Article  CAS  PubMed  Google Scholar 

  • Linnekin, D., DeBerry, C. S., & Mou, S. (1997). Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. The Journal of Biological Chemistry, 272(43), 27450–27455.

    Article  CAS  PubMed  Google Scholar 

  • Lopes, L. F., & Bacchi, C. E. (2007). EGFR and gastrointestinal stromal tumor: An immunohistochemical and FISH study of 82 cases. Modern Pathology, 20(9), 990–994. doi:10.1038/modpathol.3800932.

    Article  CAS  PubMed  Google Scholar 

  • Lotze, M. T., & DeMarco, R. A. (2003). Dealing with death: HMGB1 as a novel target for cancer therapy. Current Opinion in Investigational Drugs, 4(12), 1405–1409.

    CAS  PubMed  Google Scholar 

  • Melnick, A., & Licht, J. D. (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 93(10), 3167–3215.

    CAS  PubMed  Google Scholar 

  • Miettinen, M., & Lasota, J. (2001). Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Archiv, 438(1), 1–12.

    Article  CAS  PubMed  Google Scholar 

  • Miettinen, M., & Lasota, J. (2006). Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology & Laboratory Medicine, 130(10), 1466–1478. doi:10.1043/1543-2165(2006)130[1466:GSTROM]2.0.CO;2.

    CAS  Google Scholar 

  • Miettinen, M., Lasota, J., & Sobin, L. H. (2005). Gastrointestinal stromal tumors of the stomach in children and young adults: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. The American Journal of Surgical Pathology, 29(10), 1373–1381.

    Article  PubMed  Google Scholar 

  • Nagata, K., Kawakami, T., Kurata, Y., Kimura, Y., Suzuki, Y., Nagata, T., Sakuma, Y., Miyagi, Y., & Hirano, H. (2015). Augmentation of multiple protein kinase activities associated with secondary imatinib resistance in gastrointestinal stromal tumors as revealed by quantitative phosphoproteome analysis. Journal of Proteomics, 115, 132–142. doi:10.1016/j.jprot.2014.12.012.

    Article  CAS  PubMed  Google Scholar 

  • Okamoto, Y., Sawaki, A., Ito, S., Nishida, T., Takahashi, T., Toyota, M., Suzuki, H., Shinomura, Y., Takeuchi, I., Shinjo, K., An, B., Ito, H., Yamao, K., Fujii, M., Murakami, H., Osada, H., Kataoka, H., Joh, T., Sekido, Y., & Kondo, Y. (2012). Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour. Gut, 61(3), 392–401. doi:10.1136/gut.2011.241034.

    Article  CAS  PubMed  Google Scholar 

  • Orita, H., Ito, T., Kushida, T., Sakurada, M., Maekawa, H., Wada, R., Suehara, Y., Kubota, D., & Sato, K. (2014). Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors. BioMedical Research International, 2014, 651935. doi:10.1155/2014/651935.

    Article  Google Scholar 

  • Patel, S. R., Vadhan-Raj, S., Burgess, M. A., Plager, C., Papadopolous, N., Jenkins, J., & Benjamin, R. S. (1998). Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. American Journal of Clinical Oncology, 21(3), 317–321.

    Article  CAS  PubMed  Google Scholar 

  • Patel, S. R., Gandhi, V., Jenkins, J., Papadopolous, N., Burgess, M. A., Plager, C., Plunkett, W., & Benjamin, R. S. (2001). Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. Journal of Clinical Oncology, 19(15), 3483–3489.

    CAS  PubMed  Google Scholar 

  • Prakash, S., Sarran, L., Socci, N., DeMatteo, R. P., Eisenstat, J., Greco, A. M., Maki, R. G., Wexler, L. H., LaQuaglia, M. P., Besmer, P., & Antonescu, C. R. (2005). Gastrointestinal stromal tumors in children and young adults: A clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. Journal of Pediatric Hematology/Oncology, 27(4), 179–187.

    Article  PubMed  Google Scholar 

  • Resendes, B. L., Kuo, S. F., Robertson, N. G., Giersch, A. B., Honrubia, D., Ohara, O., Adams, J. C., & Morton, C. C. (2004). Isolation from cochlea of a novel human intronless gene with predominant fetal expression. Journal of the Association for Research in Otolaryngology, 5(2), 185–202. doi:10.1007/s10162-003-4042-x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ridky, T. W., Chow, J. M., Wong, D. J., & Khavari, P. A. (2010). Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nature Medicine, 16(12), 1450–1455. doi:10.1038/nm.2265.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007). Gastrointestinal stromal tumour. Lancet, 369(9574), 1731–1741. doi:S0140-6736(07)60780-6 [pii]10.1016/S0140-6736(07)60780-6.

    Article  CAS  PubMed  Google Scholar 

  • Salomoni, P., Ferguson, B. J., Wyllie, A. H., & Rich, T. (2008). New insights into the role of PML in tumour suppression. Cell Research, 18(6), 622–640. doi:10.1038/cr.2008.58.

    Article  CAS  PubMed  Google Scholar 

  • Saponara, M., Urbini, M., Astolfi, A., Indio, V., Ercolani, G., Del Gaudio, M., Santini, D., Pirini, M. G., Fiorentino, M., Nannini, M., Lolli, C., Mandrioli, A., Gatto, L., Brandi, G., Biasco, G., Pinna, A. D., & Pantaleo, M. A. (2015). Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRalpha genotype evaluated by next generation sequencing (NGS). Oncotarget, 6(39), 42243–42257. doi:10.18632/oncotarget.6278.

    PubMed  PubMed Central  Google Scholar 

  • Sato, H., Hasegawa, T., Abe, Y., Sakai, H., & Hirohashi, S. (1999). Expression of E-cadherin in bone and soft tissue sarcomas: A possible role in epithelial differentiation. Human Pathology, 30(11), 1344–1349.

    Article  CAS  PubMed  Google Scholar 

  • Scaife, C. L., Hunt, K. K., Patel, S. R., Benjamin, R. S., Burgess, M. A., Chen, L. L., Trent, J., Raymond, A. K., Cormier, J. N., Pisters, P. W., Pollock, R. E., & Feig, B. W. (2003). Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? The American Journal of Surgery, 186(6), 665–669.

    Article  PubMed  Google Scholar 

  • Serrels, A., McLeod, K., Canel, M., Kinnaird, A., Graham, K., Frame, M. C., & Brunton, V. G. (2012). The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells. International Journal of Cancer, 131(2), 287–297. doi:10.1002/ijc.26351.

    Article  CAS  PubMed  Google Scholar 

  • Shaw, J., Rowlinson, R., Nickson, J., Stone, T., Sweet, A., Williams, K., & Tonge, R. (2003). Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics, 3(7), 1181–1195. doi:10.1002/pmic.200300439.

    Article  CAS  PubMed  Google Scholar 

  • Shi, Z., Huang, Q., Chen, J., Yu, P., Wang, X., Qiu, H., Chen, Y., & Dong, Y. (2015). Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder. American Journal of Translational Research, 7(10), 2015–2025.

    PubMed  PubMed Central  Google Scholar 

  • Shrivastava, S., Mansure, J. J., Almajed, W., Cury, F., Ferbeyre, G., Popovic, M., Seuntjens, J., & Kassouf, W. (2015). The role of HMGB1 in radio-resistance of bladder cancer. Molecular Cancer Therapeutics. doi:10.1158/1535-7163.MCT-15-0581.

    PubMed  Google Scholar 

  • Silvestris, N., Parra, H. S., Angelini, F., Di Cosimo, S., D’Aprile, M., & Santoro, A. (2005). Lack of response to imatinib mesylate as second-line therapy in a patient with c-kit positive metastatic soft tissue leiomyosarcoma. Tumori, 91(1), 103.

    PubMed  Google Scholar 

  • Stiller, C. (2007). Childhood cancer in Britian: Incidence, survival, mortality (Vol. VII). New York: Oxford University Press.

    Book  Google Scholar 

  • Suehara, Y., Kondo, T., Fujii, K., Hasegawa, T., Kawai, A., Seki, K., Beppu, Y., Nishimura, T., Kurosawa, H., & Hirohashi, S. (2006). Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics, 6(15), 4402–4409. doi:10.1002/pmic.200600196.

    Article  CAS  PubMed  Google Scholar 

  • Suehara, Y., Kondo, T., Seki, K., Shibata, T., Fujii, K., Gotoh, M., Hasegawa, T., Shimada, Y., Sasako, M., Shimoda, T., Kurosawa, H., Beppu, Y., Kawai, A., & Hirohashi, S. (2008). Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clinical Cancer Research, 14(6), 1707–1717. doi:14/6/1707 [pii]10.1158/1078-0432.CCR-07-1478.

    Article  CAS  PubMed  Google Scholar 

  • Suehara, Y., Kikuta, K., Nakayama, R., Fujii, K., Ichikawa, H., Shibata, T., Seki, K., Hasegawa, T., Gotoh, M., Tochigi, N., Shimoda, T., Shimada, Y., Sano, T., Beppu, Y., Kurosawa, H., Hirohashi, S., Kawai, A., & Kondo, T. (2009). Anatomic site-specific proteomic signatures of gastrointestinal stromal tumors. Proteomics – Clinical Applications, 3(5), 584–596. doi:10.1002/prca.200800168.

    Article  CAS  Google Scholar 

  • Sugiura, T., Sakurai, K., & Nagano, Y. (2007). Intracellular characterization of DDX39, a novel growth-associated RNA helicase. Experimental Cell Research, 313(4), 782–790. doi:S0014-4827(06)00486-1 [pii]10.1016/j.yexcr.2006.11.014.

    Article  CAS  PubMed  Google Scholar 

  • Taguchi, T., Sonobe, H., Toyonaga, S., Yamasaki, I., Shuin, T., Takano, A., Araki, K., Akimaru, K., & Yuri, K. (2002). Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor. Laboratory Investigation, 82(5), 663–665.

    Article  PubMed  Google Scholar 

  • Takahashi, T., Serada, S., Ako, M., Fujimoto, M., Miyazaki, Y., Nakatsuka, R., Ikezoe, T., Yokoyama, A., Taguchi, T., Shimada, K., Kurokawa, Y., Yamasaki, M., Miyata, H., Nakajima, K., Takiguchi, S., Mori, M., Doki, Y., Naka, T., & Nishida, T. (2013). New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis. International Journal of Cancer, 133(11), 2737–2743. doi:10.1002/ijc.28282.

    CAS  PubMed  Google Scholar 

  • Tang, D., Kang, R., Zeh, H. J., 3rd, & Lotze, M. T. (2010). High-mobility group box 1 and cancer. Biochimica et Biophysica Acta, 1799(1–2), 131–140. doi:10.1016/j.bbagrm.2009.11.014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Timokhina, I., Kissel, H., Stella, G., & Besmer, P. (1998). Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Rac1 and JNK activation in mast cell proliferation. The EMBO Journal, 17(21), 6250–6262. doi:10.1093/emboj/17.21.6250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tran, T., Davila, J. A., & El-Serag, H. B. (2005). The epidemiology of malignant gastrointestinal stromal tumors: An analysis of 1,458 cases from 1992 to 2000. The American Journal of Gastroenterology, 100(1), 162–168. doi:10.1111/j.1572-0241.2005.40709.x.

    Article  PubMed  Google Scholar 

  • Trent, J. C., Beach, J., Burgess, M. A., Papadopolous, N., Chen, L. L., Benjamin, R. S., & Patel, S. R. (2003). A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer, 98(12), 2693–2699. doi:10.1002/cncr.11875.

    Article  CAS  PubMed  Google Scholar 

  • Tuveson, D. A., Willis, N. A., Jacks, T., Griffin, J. D., Singer, S., Fletcher, C. D., Fletcher, J. A., & Demetri, G. D. (2001). STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications. Oncogene, 20(36), 5054–5058. doi:10.1038/sj.onc.1204704.

    Article  CAS  PubMed  Google Scholar 

  • Unlu, M., Morgan, M. E., & Minden, J. S. (1997). Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis, 18(11), 2071–2077. doi:10.1002/elps.1150181133.

    Article  CAS  PubMed  Google Scholar 

  • Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E., Faversani, A., Coggi, G., Flavin, R., Bosari, S., & Loda, M. (2010). Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proceedings of the National Academy of Sciences of the United States of America, 107(18), 8352–8356. doi:10.1073/pnas.0907676107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verweij, J., Casali, P. G., Zalcberg, J., LeCesne, A., Reichardt, P., Blay, J. Y., Issels, R., van Oosterom, A., Hogendoorn, P. C., Van Glabbeke, M., Bertulli, R., & Judson, I. (2004). Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial. Lancet, 364(9440), 1127–1134. doi:10.1016/S0140-6736(04)17098-0S0140673604170980 [pii].

    Article  CAS  PubMed  Google Scholar 

  • Wang, F., Hansen, R. K., Radisky, D., Yoneda, T., Barcellos-Hoff, M. H., Petersen, O. W., Turley, E. A., & Bissell, M. J. (2002). Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. Journal of the National Cancer Institute, 94(19), 1494–1503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wardelmann, E., Thomas, N., Merkelbach-Bruse, S., Pauls, K., Speidel, N., Buttner, R., Bihl, H., Leutner, C. C., Heinicke, T., & Hohenberger, P. (2005). Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations. The Lancet Oncology, 6(4), 249–251. doi:10.1016/S1470-2045(05)70097-8.

    Article  CAS  PubMed  Google Scholar 

  • Yamada, K. M., & Cukierman, E. (2007). Modeling tissue morphogenesis and cancer in 3D. Cell, 130(4), 601–610. doi:10.1016/j.cell.2007.08.006.

    Article  CAS  PubMed  Google Scholar 

  • Yamaguchi, U., Nakayama, R., Honda, K., Ichikawa, H., Hasegawa, T., Shitashige, M., Ono, M., Shoji, A., Sakuma, T., Kuwabara, H., Shimada, Y., Sasako, M., Shimoda, T., Kawai, A., Hirohashi, S., & Yamada, T. (2008). Distinct gene expression-defined classes of gastrointestinal stromal tumor. Journal of Clinical Oncology, 26(25), 4100–4108. doi:10.1200/JCO.2007.14.2331.

    Article  CAS  PubMed  Google Scholar 

  • Yang, J., Eddy, J. A., Pan, Y., Hategan, A., Tabus, I., Wang, Y., Cogdell, D., Price, N. D., Pollock, R. E., Lazar, A. J., Hunt, K. K., Trent, J. C., & Zhang, W. (2010). Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Molecular & Cellular Proteomics, 9(11), 2405–2413. doi:10.1074/mcp.M110.000240.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by supported by the Practical Research for Innovative Cancer Control (15ck0106089h0002) from Japan Agency for Medical Research and Development (AMED), and the National Cancer Center Research and Development Fund (26-A-9).

Author information

Authors and Affiliations

  1. Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Tadashi Kondo

Authors
  1. Tadashi Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadashi Kondo .

Editor information

Editors and Affiliations

  1. Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, Texas, USA

    Ákos Végvári

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kondo, T. (2016). Proteogenomics for the Study of Gastrointestinal Stromal Tumors. In: Végvári, Á. (eds) Proteogenomics. Advances in Experimental Medicine and Biology, vol 926. Springer, Cham. https://doi.org/10.1007/978-3-319-42316-6_9

Download citation

Publish with us

Policies and ethics

Search

Navigation